Journal article
Circulating gluten-specific FOXP3 CD39 regulatory T cells have impaired suppressive function in patients with celiac disease
L Cook, CML Munier, N Seddiki, D van Bockel, N Ontiveros, MY Hardy, JK Gillies, MK Levings, HH Reid, J Petersen, J Rossjohn, RP Anderson, JJ Zaunders, JA Tye-Din, AD Kelleher
Journal of Allergy and Clinical Immunology | MOSBY-ELSEVIER | Published : 2017
Abstract
Background Celiac disease is a chronic immune-mediated inflammatory disorder of the gut triggered by dietary gluten. Although the effector T-cell response in patients with celiac disease has been well characterized, the role of regulatory T (Treg) cells in the loss of tolerance to gluten remains poorly understood. Objective We sought to define whether patients with celiac disease have a dysfunction or lack of gluten-specific forkhead box protein 3 (FOXP3)+ Treg cells. Methods Treated patients with celiac disease underwent oral wheat challenge to stimulate recirculation of gluten-specific T cells. Peripheral blood was collected before and after challenge. To comprehensively measure the gluten..
View full abstractRelated Projects (1)
Grants
Awarded by NHMRC
Awarded by Australian Research Council Australia Laureate Fellowship
Awarded by National Health and Medical Research Council
Awarded by National Health and Medical Research Council of Australia
Funding Acknowledgements
Supported by the Australian Government Department of Health and Ageing; the NHMRC through a program (510448) grant, NHMRC project grant (1085875), an Australian Research Council Australia Laureate Fellowship (FL160100049) (to J.R.), and a Practitioner Fellowship (to A. D.K.); a Coeliac Research Fund Grant (to N.S., R.P.A., J.T.-D., and A. D.K.); an Australian Postgraduate Award; and a UNSW Research Excellence Scholarship (to L.C.). H.H.R. has received a grant from the National Health and Medical Research Council (1085875).